Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar with renal dosing is prudent.
Bariatric surgery history: altered anatomy, altered expectations
post #8 answers the question as asked. The question underneath it is different.
Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is manageable with attention.
Picking up post #9: that is the part I would want checked first.
Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally established. Conservative approaches wait several months to allow clearance.
Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
I read post #35 twice before replying, because I had assumed the opposite.
Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Read the full topic (40 posts)
This topic was referenced in
- About the Special populations categoryClinical › Special populations · 4 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: History of disordered eating and why it changes the conversation
Posting this under the heading it deserves: History of disordered eating and why it changes the conversation Everything below is what sits behind that. General question, not a request for advice about my own…
|
+75 | 81 | 23k | 10mo |
|
Hepatic impairment and the absence of data
Hepatic impairment and the absence of data — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this class mostly…
|
+30 | 35 | 32k | 10mo |
|
Coming back to: Bariatric surgery history: altered anatomy, altered expectations
Bariatric surgery history: altered anatomy, altered expectations Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
2 | 38k | 15mo | |
|
Pregnancy and pregnancy planning: contraindication and washout
Posting this under the heading it deserves: Pregnancy and pregnancy planning: contraindication and washout Everything below is what sits behind that. General question, not a request for advice about my own…
|
+111 | 122 | 2.4k | 3mo |
|
Type 1 diabetes: off-label use and the evidence gap — what changed since
Type 1 diabetes: off-label use and the evidence gap — what changed since — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The…
|
+68 | 77 | 31k | 20mo |
Related topics — sharing the tags pregnancy & planning, disordered eating, older adults
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Hepatic impairment and the absence of data — a second dataset
On the subject in the title: Hepatic impairment and the absence of data — a second dataset Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in…
|
2 | 4.3k | 4mo | |
|
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
|
+4 | 8 | 23k | 8mo |
|
Anxiety in the first weeks: drug, situation, or both — what changed since
Anxiety in the first weeks: drug, situation, or both — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a…
|
+88 | 95 | 4.5k | 5mo |
|
Type 1 diabetes: off-label use and the evidence gap
On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference…
|
2 | 2.3k | 1d | |
|
[2026 update] Mood changes: monitoring, and when to involve a professional
Posting this under the heading it deserves: Mood changes: monitoring, and when to involve a professional Everything below is what sits behind that. General question, not a request for advice about my own care…
|
+12 | 17 | 300 | 11mo |